Herpetic Simplex keratitis – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

 A herpetic simplex keratitis is a form of keratitis caused by recurrent herpes simplex virus (HSV) infection in the cornea. It begins with the infection of epithelial cells on the eye's surface and retrograde infection of nerves serving the cornea. Primary infection is characterized by swelling of the conjunctiva and eyelids (Blepharoconjunctivitis) and small white itchy lesions on the corneal surface. The severity of the lesions varies, ranging from minor epithelial damage (superficial punctate keratitis) to more severe consequences such as the formation of dendritic ulcers. Humans are commonly infected with HSV. It is estimated that one-third of the world's population is infected regularly. Keratitis caused by HSV is the leading cause of corneal blindness in developed countries. As a result, HSV infections are a significant and global public health issue. Herpes simplex virus (HSV) is a ubiquitous DNA virus that can infect virtually anywhere in the body, particularly when newborns are infected. However, in an individual with a standard immune system, the most common sites of infection are the mouth, genitalia, and eyes. In very young children and adults, the brain may also become infected in rare instances. HSV infections of the eye are the leading cause of infectious corneal blindness in developed countries. While most infections are unilateral, some percentage of affected individuals have bilateral ocular infections. Bilateral infections are seen primarily in immunocompromised patients. Infections can occur in anterior aposteyeye segments eye, but it most commonly infects the corneal epithelia.

·       The incidence of Herpetic simplex keratitis ranges from 15 to 20 cases per 100,000 population in the USA.

 

Thelansis’s “Herpetic Simplex keratitis Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Herpetic Simplex keratitis treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

 

KOLs insights of Herpetic Simplex keratitis across 8 MM market from the centre of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteristics, future treatment paradigm, and Unmet needs.

Herpetic Simplex keratitis Market Forecast Patient Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs with sourcing, Market Event, and Product Event, Country specific Forecast Model, Market uptake and patient share uptake, Attribute Analysis, Analog Analysis, Disease burden, and pricing scenario, Summary, and Insights.

Thelansis Competitive Intelligence (CI) practice has been established based on a deep understanding of the pharma/biotech business environment to provide an optimized support system to all levels of the decision-making process. It enables business leaders in forward-thinking and proactive decision-making. Thelansis supports scientific and commercial teams in seamless CI support by creating an AI/ ML-based technology-driven platform that manages the data flow from primary and secondary sources.

Read more: Herpetic Simplex keratitis – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Tags: Herpetic Simplex keratitis, Herpetic Simplex keratitis market outlook, Herpetic Simplex keratitis competitive landscape, Herpetic Simplex keratitis market forecast, Thelansis, Primary market research, KOL insights, Competitive Intelligence (CI)